Cite
MLA Citation
Laura M. Spring et al.. “Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations.” Oncologist, vol. 22, 2017, pp. 1039–1048. http://access.bl.uk/ark:/81055/vdc_100071672787.0x00002f